sabato, settembre 27, 2008
antidoping laboratory standards
The World Conference on Doping in Sport held in Lausanne on 2-4 February 1999 produced the Lausanne Declaration on Doping in Sport. This document provided for the creation of an independent international anti-doping agency to be fully operational for the Games of the XXVII Olympiad in Sydney in 2000. Pursuant to the terms of the Lausanne Declaration, the World Anti-Doping Agency was established on 10 November 1999 in Lausanne to promote and coordinate the fight against doping in sport internationally. WADA was set up as a foundation under the initiative of the IOC with the support and participation of intergovernmental organizations, governments, public authorities, and other public and private bodies fighting against doping in sport. The agency consists of equal representatives from the Olympic Movement and public authorities.
http://www.wada-ama.org/en/dynamic.ch2?pageCategory.id=372
Download Center
International Standard for Laboratories (version 5.0) (Effective January 1, 2008)
Minimum Required Performance Limits for Detection of Prohibited Substances
Identification Criteria for Qualitative Assays Incorporating Chromatography and Mass Spectrometry
Laboratory Internal Chain of Custody
Laboratory Documentation Packages
Reporting and Evaluation Guidance for Testosterone, Epitestosterone, T/E Ratio and other Endogenous Steroids
Reporting Norandrosterone Findings
Harmonization of the Method for the Identification of Epoetin Alfa and Beta (rEPO) and Darbepoetin Alfa (NESP) by IEF-Double Blotting and Chemiluminescent Detection
Click per la fonte originale
http://www.wada-ama.org/en/dynamic.ch2?pageCategory.id=372
Download Center
International Standard for Laboratories (version 5.0) (Effective January 1, 2008)
Minimum Required Performance Limits for Detection of Prohibited Substances
Identification Criteria for Qualitative Assays Incorporating Chromatography and Mass Spectrometry
Laboratory Internal Chain of Custody
Laboratory Documentation Packages
Reporting and Evaluation Guidance for Testosterone, Epitestosterone, T/E Ratio and other Endogenous Steroids
Reporting Norandrosterone Findings
Harmonization of the Method for the Identification of Epoetin Alfa and Beta (rEPO) and Darbepoetin Alfa (NESP) by IEF-Double Blotting and Chemiluminescent Detection